Hrt Financial LP Sc Pharmaceuticals Inc. Transaction History

Hrt Financial LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$5.59 - $9.47 $364,456 - $617,425	65,198 New	65,198 $591,000
Q4 2021 Feb 14, 2022	SELL	$3.88 - $6.9 $62,813 - $111,704	-16,189 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$4.93 - $7.15 $20,074 - $29,114	-4,072 Reduced 20.1%	16,189 $107,000
Q2 2021 Aug 16, 2021	BUY	$5.19 - $7.38 $105,154 - $149,526	20,261 New	20,261 $123,000

37.1M

110K

12.1K

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $94.8M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.